Brief: Scope Fluidics Decides To Start FDA Certification Process For Bacteromic System
03/04/2025 13:46
April 3 (Reuters) - Scope Fluidics SA SCPP.WA: DECIDES TO START FDA CERTIFICATION PROCESS FOR BACTEROMIC SYSTEM PRE-SUBMISSION FOR BACTEROMIC SYSTEM PLANNED FOR 2025 Source text: ID:nEM5Fb9gqa Further company coverage: SCPP.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
Brief: Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
Brief: Scope Fluidics Q1 Net Loss At 13.5 Million Zlotys
Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
Brief: Scope Fluidics FY Net Loss At 46.4 Million Zlotys